Activation of platelets in platelet-rich plasma by rotablation is speed- dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro)

Marlene S. Williams, Barry S. Coller, Heikki J. Väänänen, Lesley E. Scudder, Samin K. Sharma, Jonathan D. Marmur

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Activation of platelets in platelet-rich plasma by rotablation is speed- dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro)'. Together they form a unique fingerprint.

Medicine & Life Sciences